<DOC>
	<DOC>NCT01684345</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.</brief_summary>
	<brief_title>Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<criteria>Diagnosis of noninfectious intermediate, posterior, or pan uveitis in at least one eye Active uveitic disease in at least one eye Currently on one of the following stable treatment regimens for uveitis: oral corticosteroids; systemic immunosuppressive medication; a combination of oral corticosteroids with at least one systemic immunosuppressive medication Effective contraceptive measures Infectious uveitis and masquerade syndromes Isolated anterior uveitis Contraindication to mydriatics History of allergic or anaphylactic reactions to monoclonal antibodies Active tuberculosis disease History of recurrent infection or predisposition to infection; active ocular infection Pregnant or nursing women Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Non-infectious Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Posterior Uveitis</keyword>
	<keyword>Panuveitis</keyword>
</DOC>